Endocrine disruptor regulation of microRNA expression in breast carcinoma cells

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Tilghman, Syreeta L ^a,b   Bratton, Melyssa R ^b,c   Segar, H Chris ^c   Martin, Elizabeth C ^c   Rhodes, Lyndsay V ^c   Li, Meng ^d   McLachlan, John A ^b,c   Wiese, Thomas E ^a,b   Nephew, Kenneth P ^d   Burow, Matthew E ^b,c  

^a XAVIER UNIVERSITY OF LOUISIANA   (United States)

^b TULANE UNIVERSITY   (United States)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,1,1 TRICHLORO 2 (2 CHLOROPHENYL) 2 (4 CHLOROPHENYL)ETHANE; 4,4' ISOPROPYLIDENEDIPHENOL; ENDOCRINE DISRUPTOR; ESTROGEN; FAS ANTIGEN; MICRORNA; MICRORNA 21; PROSTAGLANDIN E2; PROTEIN C JUN; CHLORPHENOTANE; ESTROGEN RECEPTOR ALPHA; MIRN21 MICRORNA, HUMAN; PHENOL DERIVATIVE; TRANSCRIPTOME;

ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER CELL CULTURE; CATHEPSIN D GENE; CELL STRAIN MCF 7; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; FAS GENE; GAMMA AMINOBUTYRIC ACID A RECEPTOR PI GENE; GELSOLIN GENE; GENE EXPRESSION REGULATION; HORMONE SENSITIVITY; HUMAN; HUMAN CELL; JUN GENE; PROGESTERONE RECEPTOR GENE; PROTEIN EXPRESSION; PROTO ONCOGENE; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DOWN REGULATION; RECEPTOR GENE; SERPIN PEPTIDASE INHIBITOR B5 GENE; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; TREFOIL FACTOR 1 GENE; BREAST TUMOR; DRUG EFFECT; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

LOTUS;

BREAST NEOPLASMS; CELL LINE, TUMOR; DDT; ENDOCRINE DISRUPTORS; ESTROGEN RECEPTOR ALPHA; ESTROGENS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; PHENOLS; TRANSCRIPTION, GENETIC; TRANSCRIPTOME;

EID: 84863268255     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032754     Document Type: Article

References (55)

1. Roy JR, Chakraborty S, Chakraborty TR, (2009) Estrogen-like endocrine disrupting chemicals affecting puberty in humans-a review. Med Sci Monit 15: RA137-145.
2. Burow ME, Tang Y, Collins-Burow BM, Krajewski S, Reed JC, et al. (1999) Effects of environmental estrogens on tumor necrosis factor alpha-mediated apoptosis in MCF-7 cells. Carcinogenesis 20: 2057-2061.
3. Frigo DE, Tang Y, Beckman BS, Scandurro AB, Alam J, et al. (2004) Mechanism of AP-1-mediated gene expression by select organochlorines through the p38 MAPK pathway. Carcinogenesis 25: 249-261.
4. Frigo DE, Burow ME, Mitchell KA, Chiang TC, McLachlan JA, (2002) DDT and its metabolites alter gene expression in human uterine cell lines through estrogen receptor-independent mechanisms. Environ Health Perspect 110: 1239-1245.
5. Bagchi G, Hurst CH, Waxman DJ, (2009) Interactions of methoxyacetic acid with androgen receptor. Toxicol Appl Pharmacol 238: 101-110.
6. Hancock KD, Coleman ES, Tao YX, Morrison EE, Braden TD, et al. (2009) Genistein decreases androgen biosynthesis in rat Leydig cells by interference with luteinizing hormone-dependent signaling. Toxicol Lett 184: 169-175.
7. Rossi M, Dimida A, Dell'anno MT, Trincavelli ML, Agretti P, et al. (2007) The thyroid disruptor 1,1,1-trichloro-2,2-bis(p-chlorophenyl)-ethane appears to be an uncompetitive inverse agonist for the thyrotropin receptor. J Pharmacol Exp Ther 320: 465-474.
8. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
9. Cuellar TL, McManus MT, (2005) MicroRNAs and endocrine biology. J Endocrinol 187: 327-332.
10. Krol J, Loedige I, Filipowicz W, The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 11: 597-610.
11. Carthew RW, Sontheimer EJ, (2009) Origins and Mechanisms of miRNAs and siRNAs. Cell 136: 642-655.
12. Ventura A, Jacks T, (2009) MicroRNAs and cancer: short RNAs go a long way. Cell 136: 586-591.
13. Nana-Sinkam SP, Croce CM, MicroRNAs as therapeutic targets in cancer. Transl Res 157: 216-225.
14. Tessel MA, Krett NL, Rosen ST, Steroid receptor and microRNA regulation in cancer. Curr Opin Oncol 22: 592-597.
15. Adams BD, Furneaux H, White BA, (2007) The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-alpha (ERalpha) and represses ERalpha messenger RNA and protein expression in breast cancer cell lines. Mol Endocrinol 21: 1132-1147.
16. Bhat-Nakshatri P, Wang G, Collins NR, Thomson MJ, Geistlinger TR, et al. (2009) Estradiol-regulated microRNAs control estradiol response in breast cancer cells. Nucleic Acids Res 37: 4850-4861.
17. Wickramasinghe NS, Manavalan TT, Dougherty SM, Riggs KA, Li Y, et al. (2009) Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells. Nucleic Acids Res 37: 2584-2595.
18. Cheng Y, Ji R, Yue J, Yang J, Liu X, et al. (2007) MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy? Am J Pathol 170: 1831-1840.
19. Tatsuguchi M, Seok HY, Callis TE, Thomson JM, Chen JF, et al. (2007) Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. J Mol Cell Cardiol 42: 1137-1141.
20. Urbich C, Kuehbacher A, Dimmeler S, (2008) Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc Res 79: 581-588.
21. Du J, Yang S, An D, Hu F, Yuan W, et al. (2009) BMP-6 inhibits microRNA-21 expression in breast cancer through repressing deltaEF1 and AP-1. Cell Res 19: 487-496.
22. Jiang J, Gusev Y, Aderca I, Mettler TA, Nagorney DM, et al. (2008) Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin Cancer Res 14: 419-427.
23. Pan Q, Luo X, Chegini N, (2008) Differential expression of microRNAs in myometrium and leiomyomas and regulation by ovarian steroids. J Cell Mol Med 12: 227-240.
24. Seike M, Goto A, Okano T, Bowman ED, Schetter AJ, et al. (2009) MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers. Proc Natl Acad Sci U S A 106: 12085-12090.
25. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, et al. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 103: 2257-2261.
26. Yamamichi N, Shimomura R, Inada K, Sakurai K, Haraguchi T, et al. (2009) Locked nucleic acid in situ hybridization analysis of miR-21 expression during colorectal cancer development. Clin Cancer Res 15: 4009-4016.
27. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, et al. (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070.
28. Cheng AM, Byrom MW, Shelton J, Ford LP, (2005) Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 33: 1290-1297.
29. Si ML, Zhu S, Wu H, Lu Z, Wu F, et al. (2007) miR-21-mediated tumor growth. Oncogene 26: 2799-2803.
30. Mattie MD, Benz CC, Bowers J, Sensinger K, Wong L, et al. (2006) Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol Cancer 5: 24.
31. Hsu PY, Deatherage DE, Rodriguez BA, Liyanarachchi S, Weng YI, et al. (2009) Xenoestrogen-induced epigenetic repression of microRNA-9-3 in breast epithelial cells. Cancer Res 69: 5936-5945.
32. Boue SM, Tilghman SL, Elliott S, Zimmerman MC, Williams KY, et al. (2009) Identification of the potent phytoestrogen glycinol in elicited soybean (Glycine max). Endocrinology 150: 2446-2453.
33. La Sala G, Farini D, De Felici M, (2010) Estrogenic in vitro assay on mouse embryonic Leydig cells. Int J Dev Biol 54: 717-722.
34. Tilghman SL, Nierth-Simpson EN, Wallace R, Burow ME, McLachlan JA, (2010) Environmental hormones: Multiple pathways for response may lead to multiple disease outcomes. Steroids 75: 520-523.
35. Wang F, Zheng Z, Guo J, Ding X, (2010) Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor. Gynecol Oncol 119: 586-593.
36. Zhao Y, Deng C, Wang J, Xiao J, Gatalica Z, et al. (2011) Let-7 family miRNAs regulate estrogen receptor alpha signaling in estrogen receptor positive breast cancer. Breast Cancer Res Treat 127: 69-80.
37. Fan M, Yan PS, Hartman-Frey C, Chen L, Paik H, et al. (2006) Diverse gene expression and DNA methylation profiles correlate with differential adaptation of breast cancer cells to the antiestrogens tamoxifen and fulvestrant. Cancer Res 66: 11954-11966.
38. Zhu S, Wu H, Wu F, Nie D, Sheng S, et al. (2008) MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res 18: 350-359.
39. Roldo C, Missiaglia E, Hagan JP, Falconi M, Capelli P, et al. (2006) MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol 24: 4677-4684.
40. Lockett J, Yin S, Li X, Meng Y, Sheng S, (2006) Tumor suppressive maspin and epithelial homeostasis. J Cell Biochem 97: 651-660.
41. Klotz DM, Beckman BS, Hill SM, McLachlan JA, Walters MR, et al. (1996) Identification of environmental chemicals with estrogenic activity using a combination of in vitro assays. Environ Health Perspect 104: 1084-1089.
42. Wetherill YB, Akingbemi BT, Kanno J, McLachlan JA, Nadal A, et al. (2007) In vitro molecular mechanisms of bisphenol A action. Reprod Toxicol 24: 178-198.
43. Cohen A, Shmoish M, Levi L, Cheruti U, Levavi-Sivan B, et al. (2008) Alterations in micro-ribonucleic acid expression profiles reveal a novel pathway for estrogen regulation. Endocrinology 149: 1687-1696.
44. Kovalchuk O, Tryndyak VP, Montgomery B, Boyko A, Kutanzi K, et al. (2007) Estrogen-induced rat breast carcinogenesis is characterized by alterations in DNA methylation, histone modifications and aberrant microRNA expression. Cell Cycle 6: 2010-2018.
45. Maillot G, Lacroix-Triki M, Pierredon S, Gratadou L, Schmidt S, et al. (2009) Widespread estrogen-dependent repression of micrornas involved in breast tumor cell growth. Cancer Res 69: 8332-8340.
46. Nothnick WB, Healy C, (2010) Estrogen induces distinct patterns of microRNA expression within the mouse uterus. Reprod Sci 17: 987-994.
47. Pan Q, Luo X, Toloubeydokhti T, Chegini N, (2007) The expression profile of micro-RNA in endometrium and endometriosis and the influence of ovarian steroids on their expression. Mol Hum Reprod 13: 797-806.
48. Sempere LF, Christensen M, Silahtaroglu A, Bak M, Heath CV, et al. (2007) Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Res 67: 11612-11620.
49. Bruning U, Cerone L, Neufeld Z, Fitzpatrick SF, Cheong A, et al. (2011) MicroRNA-155 Promotes Resolution of Hypoxia-Inducible Factor 1{alpha} Activity during Prolonged Hypoxia. Mol Cell Biol 31: 4087-4096.
50. Moffat ID, Boutros PC, Celius T, Linden J, Pohjanvirta R, et al. (2007) microRNAs in adult rodent liver are refractory to dioxin treatment. Toxicol Sci 99: 470-487.
51. Hengstler JG, Foth H, Gebel T, Kramer PJ, Lilienblum W, et al. Critical evaluation of key evidence on the human health hazards of exposure to bisphenol A. Crit Rev Toxicol 41: 263-291.
52. Eskenazi B, Chevrier J, Rosas LG, Anderson HA, Bornman MS, et al. (2009) The Pine River statement: human health consequences of DDT use. Environ Health Perspect 117: 1359-1367.
53. Pfaffl MW, (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45.
54. Zhu Q, Hong A, Sheng N, Zhang X, Matejko A, et al. (2007) microParaflo biochip for nucleic acid and protein analysis. Methods Mol Biol 382: 287-312.
55. Bolstad BM, Irizarry RA, Astrand M, Speed TP, (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19: 185-193.